IN8bio, Inc. (INAB)
NASDAQ: INAB · Real-Time Price · USD
1.980
-0.030 (-1.49%)
At close: Nov 28, 2025, 1:00 PM EST
1.990
+0.010 (0.51%)
After-hours: Nov 28, 2025, 4:09 PM EST
IN8bio Market Cap
IN8bio has a market cap or net worth of $9.18 million as of November 28, 2025. Its market cap has decreased by -63.82% in one year.
Market Cap
9.18M
Enterprise Value
1.44M
1-Year Change
-63.82%
Ranking
Category
Stock Price
$1.98
Market Cap Chart
Since the IPO on July 30, 2021, IN8bio's market cap has decreased from $187.55M to $9.18M, a decrease of -95.11%. That is a compound annual growth rate of -50.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 9.18M | -50.78% |
| Dec 31, 2024 | 18.64M | -68.76% |
| Dec 29, 2023 | 59.67M | 5.43% |
| Dec 30, 2022 | 56.60M | -31.25% |
| Dec 31, 2021 | 82.33M | -56.10% |
| Jul 30, 2021 | 187.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |